Subtotal nephrectomy stimulates cyclooxygenase 2 expression and prostacyclin synthesis in the rat remnant kidney

Nephron

Volumn 91, Issue 1, 2002, Pages 134-141

  Horiba, Naoshi ^a,b   Kumano, Eiichi ^a   Watanabe, Takeshi ^a   Shinkura, Hirofumi ^a   Sugimoto, Tetsuro ^a   Inoue, Makoto ^a  

^a CHUGAI PHARMACEUTICAL CO LTD   (Japan)

^b NONE   (Japan)

Author keywords

COX 1; COX 2; Five sixths nephrectomized rats; Macula densa; Prostaglandins; Renal insufficiency

Indexed keywords

CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; PROSTACYCLIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; DISEASE COURSE; ENZYME IMMUNOASSAY; ENZYME LOCALIZATION; FATTY ACID SYNTHESIS; FEMALE; IMMUNOHISTOCHEMISTRY; KIDNEY FAILURE; KIDNEY ISCHEMIA; MACULA DENSA; NEPHRECTOMY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REGULATORY MECHANISM; WESTERN BLOTTING;

ANIMALS; BLOOD UREA NITROGEN; BLOTTING, WESTERN; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DISEASE PROGRESSION; EPOPROSTENOL; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; IMMUNOENZYME TECHNIQUES; IMMUNOHISTOCHEMISTRY; ISOENZYMES; KIDNEY; KIDNEY CORTEX; KIDNEY FAILURE, CHRONIC; MEMBRANE PROTEINS; NEPHRECTOMY; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RATS; RATS, SPRAGUE-DAWLEY; UP-REGULATION;

EID: 0036098271     PISSN: 00282766     EISSN: None     Source Type: Journal    
DOI: 10.1159/000057615     Document Type: Article

References (43)

1. Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing
2. TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue
3. Localization of cyclooxygenase-1 and -2 in adult and fetal human kidney: Implication for renal function
4. Cyclooxygenase-2 is associated with the macula densa of rat kidney and increases with salt restriction
5. Cyclooxygenase-2 mediates increased renal renin content induced by low-sodium diet
6. Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse
7. Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II
8. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs
9. Biosynthesis and interaction of endothelium-derived vasoactive mediators
10. Prostaglandin endoperoxide synthase: Structure and catalysis
11. Segmental synthesis and actions of prostaglandins along the nephron
12. 2synthesis along the rabbit nephron
13. 2 production in stroke-prone spontaneously hypertensive rats
14. Effects of prostaglandins on vasoconstrictor action in isolated renal arterioles
15. Effect of prostanoids on renin release from rabbit afferent arterioles with and without macula densa
16. 2 secretion and excretion in conscious dogs
17. Nephrotoxicity of nonsteroidal anti-inflammatory drugs
18. Indomethacin-induced renal dysfunction in patients with well-compensated cirrhosis
19. Effects of acute and chronic dosing of NSAIDs in patients with renal insufficiency
20. Renal toxicity of the nonsteroidal anti-inflammatory drugs
21. The effect of indomethacin blockade of prostaglandin synthesis on blood pressure of normal rabbits and rabbits with renovascular hypertension
22. Glomerular prostaglandin and thromboxane synthesis in rat nephrotoxic serum nephritis: Effects on renal hemodynamics
23. Vasodilator prostaglandins (PG) prevent renal damage after ischemia
24. The role of prostaglandin and thromboxane synthesis by the glomeruli in the development of acute renal failure
25. Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic
26. Selective inhibition of cyclooxygenase (COX)-2 reverses inflammation and expression of COX-2 and interleukin 6 in rat adjuvant arthritis
27. Possible background mechanisms of the effectiveness of cyclooxygenase-2 inhibitors in the treatment of rheumatoid arthritis
28. Selective COX-2 inhibitors and gastrointestinal mucosal injury: Pharmacological and therapeutic considerations
29. Are selective COX-2 inhibitors nephrotoxic?
30. Renal effects of cyclo-oxygenase-type-2 inhibition
31. Renal side-effects of cyclo-oxygenase-type-2 inhibitor use
32. 3 and 22-oxacalcitriol prevent the decrease in vitamin D receptor content in the parathyroid glands of uremic rats
33. Protein measurement with the Folin phenol reagent
34. Peptide mapping by limited proteolysis in sodium dodecyl sulfate and analysis by gel electrophoresis
35. Selective increase of cyclooxygenase-2 expression in a model of renal ablation
36. Pathophysiology of hypertension in patients on renal replacement therapy
37. The renin-angiotensin system in cats with chronic renal failure
38. Kidney and hypertension: Role of the juxtaglomerular apparatus
39. Interactions among renal nerves, prostaglandins, and renal arterial pressure in the regulation of renin release
40. Acute renal failure after five-sixths nephrectomy: Histological and functional changes
41. A selective cyclooxygenase-2 inhibitor decreases proteinuria and retards progressive renal injury in rats
42. Effect of cyclooxygenase-2 inhibition on renal function in elderly persons receiving a low-salt diet: A randomized, controlled trial
43. Effects of prostaglandins on vasoconstrictor action in isolated renal arterioles